- Home
- DRRX vs FEMY Comparison
DRRX vs FEMY Comparison
Compare DRRX & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- FEMY
- Stock Information
- Founded
- DRRX 1998
- FEMY 2004
- Country
- DRRX United States
- FEMY United States
- Employees
- DRRX N/A
- FEMY N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- FEMY Medical/Dental Instruments
- Sector
- DRRX Health Care
- FEMY Health Care
- Exchange
- DRRX Nasdaq
- FEMY Nasdaq
- Market Cap
- DRRX 26.3M
- FEMY 25.0M
- IPO Year
- DRRX 2000
- FEMY 2021
- Fundamental
- Price
- DRRX $0.75
- FEMY $1.18
- Analyst Decision
- DRRX Buy
- FEMY Strong Buy
- Analyst Count
- DRRX 2
- FEMY 3
- Target Price
- DRRX $5.00
- FEMY $10.00
- AVG Volume (30 Days)
- DRRX 67.3K
- FEMY 158.7K
- Earning Date
- DRRX 03-26-2025
- FEMY 03-27-2025
- Dividend Yield
- DRRX N/A
- FEMY N/A
- EPS Growth
- DRRX N/A
- FEMY N/A
- EPS
- DRRX N/A
- FEMY N/A
- Revenue
- DRRX $8,594,000.00
- FEMY $1,260,643.00
- Revenue This Year
- DRRX $54.32
- FEMY $157.75
- Revenue Next Year
- DRRX N/A
- FEMY $254.07
- P/E Ratio
- DRRX N/A
- FEMY N/A
- Revenue Growth
- DRRX N/A
- FEMY 15.33
- 52 Week Low
- DRRX $0.68
- FEMY $0.76
- 52 Week High
- DRRX $1.88
- FEMY $2.40
- Technical
- Relative Strength Index (RSI)
- DRRX 38.86
- FEMY 56.19
- Support Level
- DRRX $0.71
- FEMY $1.09
- Resistance Level
- DRRX $0.85
- FEMY $1.20
- Average True Range (ATR)
- DRRX 0.06
- FEMY 0.08
- MACD
- DRRX -0.01
- FEMY 0.01
- Stochastic Oscillator
- DRRX 26.38
- FEMY 66.67
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.